Swantek J, Cobb M, Geppert T
Mol Cell Biol. 1997; 17(11):6274-82.
PMID: 9343388
PMC: 232478.
DOI: 10.1128/MCB.17.11.6274.
Norman K, Williams T, Feldmann M, Rossi A
Br J Pharmacol. 1996; 117(3):471-478.
PMID: 8821536
PMC: 1909294.
DOI: 10.1111/j.1476-5381.1996.tb15214.x.
Yoneda K, Osaki T, Yamamoto T, Ueta E
Clin Exp Immunol. 1993; 93(2):229-36.
PMID: 8348749
PMC: 1554840.
DOI: 10.1111/j.1365-2249.1993.tb07971.x.
Nagai M, Saigusa T, Shimada Y, Inagawa H, Oshima H, Iriki M
Experientia. 1988; 44(7):606-7.
PMID: 3396657
DOI: 10.1007/BF01953311.
Sun X, Hsueh W
J Clin Invest. 1988; 81(5):1328-31.
PMID: 3366898
PMC: 442560.
DOI: 10.1172/JCI113459.
Ocular inflammatory effects of intravitreally-injected tumor necrosis factor.
Rosenbaum J, HOWES Jr E, Rubin R, Samples J
Am J Pathol. 1988; 133(1):47-53.
PMID: 3263050
PMC: 1880652.
Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.
Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A
J Exp Med. 1986; 164(5):1791-6.
PMID: 3095481
PMC: 2188450.
DOI: 10.1084/jem.164.5.1791.
Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
Sherry B, Cerami A
J Cell Biol. 1988; 107(4):1269-77.
PMID: 3049617
PMC: 2115248.
DOI: 10.1083/jcb.107.4.1269.
Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation.
Beutler B, Cerami A
Immunol Res. 1986; 5(4):281-93.
PMID: 3036973
DOI: 10.1007/BF02935501.
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
Dayer J, Beutler B, Cerami A
J Exp Med. 1985; 162(6):2163-8.
PMID: 2999289
PMC: 2187983.
DOI: 10.1084/jem.162.6.2163.
Cytotoxin from polymorphonuclear leukocytes and inflammatory ascitic fluids.
Yamazaki M, Ikenami M, Sugiyama T
Br J Cancer. 1989; 59(3):353-5.
PMID: 2930699
PMC: 2247070.
DOI: 10.1038/bjc.1989.70.
Tumor necrosis factor induces glomerular damage in the rabbit.
Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P
Am J Pathol. 1989; 134(2):419-30.
PMID: 2916653
PMC: 1879578.
Cachectin alters anterior pituitary hormone release by a direct action in vitro.
Milenkovic L, Rettori V, Snyder G, Beutler B, McCANN S
Proc Natl Acad Sci U S A. 1989; 86(7):2418-22.
PMID: 2564680
PMC: 286924.
DOI: 10.1073/pnas.86.7.2418.
Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.
Lau A, Livesey J
J Clin Invest. 1989; 84(3):738-43.
PMID: 2503543
PMC: 329714.
DOI: 10.1172/JCI114231.
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.
Nathan C
J Clin Invest. 1987; 80(6):1550-60.
PMID: 2445780
PMC: 442423.
DOI: 10.1172/JCI113241.
Reduced amino acid transport in skeletal muscle caused by a circulating factor during endotoxemia.
Warner B, Hasselgren P, James J, Hummel 3rd R, Rigel D, Fischer J
Ann Surg. 1990; 211(3):323-8.
PMID: 2178567
PMC: 1358438.
DOI: 10.1097/00000658-199003000-00003.
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
Gatanaga T, Hwang C, Kohr W, Cappuccini F, Lucci 3rd J, Jeffes E
Proc Natl Acad Sci U S A. 1990; 87(22):8781-4.
PMID: 2174164
PMC: 55043.
DOI: 10.1073/pnas.87.22.8781.